Delequamine

CAS No. 119905-05-4

Delequamine( —— )

Catalog No. M36152 CAS No. 119905-05-4

Delequamine (RS 15385-197) is a selective and potent TNIK inhibitor (IC50: 8 nM).TINK-IN-1 inhibits colorectal cancer cell viability and can be used to study mental retardation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 392 Get Quote
5MG 615 Get Quote
10MG 873 Get Quote
25MG 1270 Get Quote
50MG 1711 Get Quote
100MG 2241 Get Quote
500MG 4437 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Delequamine
  • Note
    Research use only, not for human use.
  • Brief Description
    Delequamine (RS 15385-197) is a selective and potent TNIK inhibitor (IC50: 8 nM).TINK-IN-1 inhibits colorectal cancer cell viability and can be used to study mental retardation.
  • Description
    Delequamine (RS 15385-197) is a selective and potent TNIK inhibitor (IC50: 8 nM).TINK-IN-1 inhibits colorectal cancer cell viability and can be used to study mental retardation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    119905-05-4
  • Formula Weight
    350.48
  • Molecular Formula
    C18H26N2O3S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    S(C)(=O)(=O)N1[C@]2(C[C@]3(C=4C(=CC(OC)=CC4)CCN3C[C@]2(CCC1)[H])[H])[H]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • ORM-10921

    ORM-10921 is an α2C-adrenoceptor antagonist that has shown antipsychotic and antidepressant activity in animal studies.

  • Imiloxan

    Imiloxan (RS-21361) is an α2 adrenergic receptor antagonist used in the treatment of major depressive disorder.

  • (3aR,9aR)-Fluparoxan

    (3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.